Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sabrina Chiloiro

Showing results (91-100 of 117) with videos related to

Pageof 12
Sort By:
European Journal of Endocrinology|November 2, 2020
Pegvisomant and Pasireotide LAR as second line therapy in acromegaly: clinical effectiveness and predictors of responseSabrina Chiloiro, Antonella Giampietro, Federica Mirra, et al.
European Journal of Endocrinology|September 14, 2022
Susceptibility and characteristics of infections in patients with glucocorticoid excess or insufficiency: the ICARO toolMarianna Minnetti, Valeria Hasenmajer, Emilia Sbardella, et al.
Pituitary|July 6, 2013
Radically resected pituitary adenomas: prognostic role of Ki 67 labeling index in a monocentric retrospective series and literature reviewSabrina Chiloiro, Antonio Bianchi, Francesco Doglietto, et al.
Pancreas|December 3, 2024
SOMATOSTATIN ANALOGUES VS ACTIVE SURVEILLANCE IN SMALL PANCREATIC NEUROENDOCRINE TUMORSMaria Grazia Maratta, Sabrina Chiloiro, Salvatore Raia, et al.
Immunity, Inflammation and Disease|May 4, 2021
Pleomorphicskin eruptions in a COVID-19 affected patient: Case report and review of the literatureEnrico Scala, Luca Fania, Filippo Bernardini, et al.
Pituitary|September 7, 2025
The clinicopathological PANOMEN-3 classification predicts pituitary adenoma prognosis: a real-world retrospective single center study of a surgically treated cohortSabrina Chiloiro, Antonella Giampietro, Raffaele Migliore, et al.
Endocrine|December 26, 2019
Tumour-infiltrating cytotoxic T lymphocytes in somatotroph pituitary neuroendocrine tumoursDonato Iacovazzo, Sabrina Chiloiro, Eivind Carlsen, et al.
Reviews in Endocrine & Metabolic Disorders|June 11, 2025
Lights or shadows, a promising future for positron emission tomography in pituitary tumors: a systematic reviewSabrina Chiloiro, Carmelo Caldarella, Alessandra Vicari, et al.
International Journal of Molecular Sciences|February 10, 2024
The Pathogenic RET Val804Met Variant in Acromegaly: A New Clinical Phenotype?Sabrina Chiloiro, Ettore Domenico Capoluongo, Flavia Costanza, et al.
Endocrine|May 1, 2026
Endocrine toxicities in immune checkpoint inhibitors and tyrosine kinase inhibitors combined treatment: from clinical trials to real-life practiceSabrina Chiloiro, Maria Grazia Maratta, Simone Antonio De Sanctis, et al.
Pageof 12

Showing results (91-100 of 117) with videos related to

Sort By:
Pageof 12
European Journal of Endocrinology|November 2, 2020
Pegvisomant and Pasireotide LAR as second line therapy in acromegaly: clinical effectiveness and predictors of responseSabrina Chiloiro, Antonella Giampietro, Federica Mirra, et al.
European Journal of Endocrinology|September 14, 2022
Susceptibility and characteristics of infections in patients with glucocorticoid excess or insufficiency: the ICARO toolMarianna Minnetti, Valeria Hasenmajer, Emilia Sbardella, et al.
Pituitary|July 6, 2013
Radically resected pituitary adenomas: prognostic role of Ki 67 labeling index in a monocentric retrospective series and literature reviewSabrina Chiloiro, Antonio Bianchi, Francesco Doglietto, et al.
Pancreas|December 3, 2024
SOMATOSTATIN ANALOGUES VS ACTIVE SURVEILLANCE IN SMALL PANCREATIC NEUROENDOCRINE TUMORSMaria Grazia Maratta, Sabrina Chiloiro, Salvatore Raia, et al.
Immunity, Inflammation and Disease|May 4, 2021
Pleomorphicskin eruptions in a COVID-19 affected patient: Case report and review of the literatureEnrico Scala, Luca Fania, Filippo Bernardini, et al.
Pituitary|September 7, 2025
The clinicopathological PANOMEN-3 classification predicts pituitary adenoma prognosis: a real-world retrospective single center study of a surgically treated cohortSabrina Chiloiro, Antonella Giampietro, Raffaele Migliore, et al.
Endocrine|December 26, 2019
Tumour-infiltrating cytotoxic T lymphocytes in somatotroph pituitary neuroendocrine tumoursDonato Iacovazzo, Sabrina Chiloiro, Eivind Carlsen, et al.
Reviews in Endocrine & Metabolic Disorders|June 11, 2025
Lights or shadows, a promising future for positron emission tomography in pituitary tumors: a systematic reviewSabrina Chiloiro, Carmelo Caldarella, Alessandra Vicari, et al.
International Journal of Molecular Sciences|February 10, 2024
The Pathogenic RET Val804Met Variant in Acromegaly: A New Clinical Phenotype?Sabrina Chiloiro, Ettore Domenico Capoluongo, Flavia Costanza, et al.
Endocrine|May 1, 2026
Endocrine toxicities in immune checkpoint inhibitors and tyrosine kinase inhibitors combined treatment: from clinical trials to real-life practiceSabrina Chiloiro, Maria Grazia Maratta, Simone Antonio De Sanctis, et al.
Pageof 12